MAI Capital Management’s OptimizeRx OPRX Stock Holding History

MAI Capital Management’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,386	Closed	-$40.1K	–	3888
2026 Q1	$40.1K	Buy	6,386 +686	+12%	+$6.37K	﹤0.01%	2381
2025 Q4	$69.9K	Hold	5,700	–	–	﹤0.01%	1828
2025 Q3	$117K	Hold	5,700	–	–	﹤0.01%	1492
2025 Q2	$77K	Hold	5,700	–	–	﹤0.01%	1625
2025 Q1	$49.4K	Hold	5,700	–	–	﹤0.01%	1749
2024 Q4	$27.7K	Buy	+5,700	New	+$31.9K	﹤0.01%	2068
2022 Q2	–	Sell	-6,800	Closed	-$256K	–	948
2022 Q1	$256K	Hold	6,800	–	–	﹤0.01%	738
2021 Q4	$422K	Hold	6,800	–	–	0.01%	619
2021 Q3	$582K	Hold	6,800	–	–	0.01%	477
2021 Q2	$421K	Hold	6,800	–	–	0.01%	533
2021 Q1	$332K	Hold	6,800	–	–	0.01%	560
2020 Q4	$212K	Buy	+6,800	New	+$167K	0.01%	615
2018 Q4	–	Sell	-13,334	Closed	-$240K	–	483
2018 Q3	$240K	Hold	13,334	–	–	0.01%	407
2018 Q2	$139K	Buy	+13,334	New	+$137K	0.01%	462

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

MAI Capital Management's OPRX Position: Q2 2026 in Review

MAI Capital Management sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 6,386 shares — an estimated $40.1K sold.

MAI Capital Management first reported a position in OPRX in Q2 2018 and held it in 14 quarters. The position peaked at $582K in Q3 2021. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

MAI Capital Management reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
MAI Capital Management sold 6,386 OptimizeRx shares in Q2 2026, an estimated $40.1K.
MAI Capital Management first reported a position in OptimizeRx in Q2 2018 and held it in 14 quarters.
MAI Capital Management's OptimizeRx position peaked at $582K in Q3 2021.
113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.